Maryam Fouladi - Concepedia

Author

Maryam Fouladi

St. Jude Children's Research Hospital ORCID

Also Known As

Fouladi, M, Fouladi, Maryam, Gertjan J. L. Kaspers, Grotzer, Michael, K. Aldape, M Fouladi, M. FOULADI, M. Fouladi, Maryam Fouladi, Nabavizadeh, Ali

473

Publications

23.1K

Citations

H-Index

100

Concepts

All Affiliations

St. Jude Children's Research Hospital Cincinnati Children's Hospital Medical Center Children's National Hospital for Sick Children University of California, San Francisco

About

Maryam Fouladi is an author at St. Jude Children's Research Hospital specializing in medicine, neuro-oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	58	10.5K
2	Health Sciences	16	18	3.6K
3	Engineering	2	2	326
4	Education	1	1	81
5	Natural Sciences	1	1	57

Maryam Fouladi

156

Publications

19.5K

Citations

H-Index

Page 1

	Year	Citations
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma Dominik Sturm, Hendrik Witt, Volker Hovestadt, Cancer Cell Neuro-oncologyRadiation OncologySomatic VariantTumor HeterogeneityGenetics	2012	1.8K
Intertumoral Heterogeneity within Medulloblastoma Subgroups Florence M.G. Cavalli, Marc Remke, Ladislav Rampášek, Cancer Cell BiologyNeuro-oncologyTumor HeterogeneityMedicineSurgical Pathology	2017	1.2K
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs Dominik Sturm, Brent A. Orr, Umut H. Toprak, Cell Neuro-oncologyMolecular ClassificationCerebral OrganoidNeurologyNeuroscience	2016	973
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial Amar Gajjar, Murali Chintagumpala, David M. Ashley, The Lancet Oncology Neuro-oncologyRisk-adapted Craniospinal RadiotherapyOncologyStem-cell RescueSpinal Oncology	2006	935
Subgroup-specific structural variation across 1,000 medulloblastoma genomes Paul A. Northcott, David Shih, John Peacock, Nature GeneticsGenomicsCancer BiologyTumor BiologyNeuro-oncology	2012	910
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma Catherine S. Grasso, Yujie Tang, Nathalène Truffaux, Nature Medicine Neuro-oncologyTherapeutic TargetsTumor TargetingNeurologyHigh-grade Gliomas	2015	686
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, Journal of Clinical Oncology	2013	474
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint, The Lancet Oncology Neuro-oncologyTumoral PathologyPediatric Brain TumorsProgressive Low-grade GliomaMedicine	2019	472
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032 Giles Robinson, Brent A. Orr, Gang Wu, Journal of Clinical Oncology	2015	448
Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy Tanya Tekautz, Christine Fuller, Susan M. Blaney, Journal of Clinical Oncology	2005	421

Page 1